Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 8

1.

Driving the Scalability of DNA-Based Information Storage Systems.

Tomek KJ, Volkel K, Simpson A, Hass AG, Indermaur EW, Tuck JM, Keung AJ.

ACS Synth Biol. 2019 Jun 21;8(6):1241-1248. doi: 10.1021/acssynbio.9b00100. Epub 2019 May 24.

PMID:
31117362
2.

Removal and upgrading of lignocellulosic fermentation inhibitors by in situ biocatalysis and liquid-liquid extraction.

Tomek KJ, Saldarriaga CR, Velasquez FP, Liu T, Hodge DB, Whitehead TA.

Biotechnol Bioeng. 2015 Mar;112(3):627-32. doi: 10.1002/bit.25473. Epub 2014 Nov 24.

PMID:
25311910
3.

The interrelationship between promoter strength, gene expression, and growth rate.

Bienick MS, Young KW, Klesmith JR, Detwiler EE, Tomek KJ, Whitehead TA.

PLoS One. 2014 Oct 6;9(10):e109105. doi: 10.1371/journal.pone.0109105. eCollection 2014.

4.

Blockade of fatty acid synthase induces ubiquitination and degradation of phosphoinositide-3-kinase signaling proteins in ovarian cancer.

Tomek K, Wagner R, Varga F, Singer CF, Karlic H, Grunt TW.

Mol Cancer Res. 2011 Dec;9(12):1767-79. doi: 10.1158/1541-7786.MCR-10-0467. Epub 2011 Oct 4.

6.

Upregulation of retinoic acid receptor-beta by the epidermal growth factor-receptor inhibitor PD153035 is not mediated by blockade of ErbB pathways.

Grunt TW, Tomek K, Wagner R, Puckmair K, Kainz B, Rünzler D, Gaiger A, Köhler G, Zielinski CC.

J Cell Physiol. 2007 Jun;211(3):803-15.

PMID:
17286282
7.

An EGF receptor inhibitor induces RAR-beta expression in breast and ovarian cancer cells.

Grunt TW, Puckmair K, Tomek K, Kainz B, Gaiger A.

Biochem Biophys Res Commun. 2005 Apr 22;329(4):1253-9.

PMID:
15766561
8.

[Bacteriological investigation in the environment of patients with active tuberculosis].

MUHLENBACH V, TOMEK K.

Tuberkulosearzt. 1952 Mar;6(3):174-7. Undetermined Language. No abstract available.

PMID:
14958861

Supplemental Content

Support Center